Intensity Therapeutics scores $10 mln
Intensity Therapeutics Inc, a developer of cancer immunotherapy products, has raised $10 million in financing. The investors included Batterson Venture Capital, VCapital, FastForward Innovations and SalvaRx Group PLC.
28 June 2016•1 min read
